In line with those results, we continued to examine whether FZD3 can be used as an adjunct diagnostic marker for metastatic CRC by performing FZD3 ICC staining in 310 non-CRC metastatic carcinoma specimens. Here, FZD3 is linked to colorectal carcinoma.